CRYSTALLINE SALTS OF 2-(4-{2-[2-HYDROXY-3-(2-THIOPHEN-2-YL-PHENOXY)-PROPYLAMINO]-2-METHYL-PROPYL}-PHENOXY)-NICOTINONITRILE

摘要

The present invention relates to crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile. The salts of the present invention, being beta 3 adrenergic receptor agonists, are capable of increasing lipolysis and energy expenditure in cells and, therefore, are useful, e.g., for treating type 2 diabetes and/or obesity.